Journals / Acıbadem Üniversitesi Sağlık Bilimleri Dergisi / 2020 / Sayı: 3

Susceptibility-Weighted Imaging In Grading of Infiltrative Glial Tumors

İNFİLTRATİF GLİAL TÜMÖR EVRELEMESİNDE SUSCEPTİBİLİTY AĞIRLIKLI GÖRÜNTÜLEME

Pages
488–493
Publication Date
2020-09-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These data suggest that the presence rather than the number of ITSS yields more information on the grade of this type of tumor

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Histopathological and radiological examination is necessary for the evaluation of tumor types and staging.
📊
Key Findings & Data:The purpose of the present study was to evaluate susceptibility-weighted imaging SWI the in grading of infiltrative glial tumors.Materials and Methods: The SWI sequences in pre-operative magnetic resonance imaging MRI images were retrospectively assessed in a total of 67 patients mean age, 36.7 years; age range, 4–79 years; 29 female, 38 male who were diagnosed with a glial tumor based on histopathological examination.
💡
Conclusion & Impact:These data suggest that the presence rather than the number of ITSS yields more information on the grade of this type of tumor
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Glial tumor · susceptibility-weighted imaging SWI

Abstract

Purpose: Histopathological and radiological examination is necessary for the evaluation of tumor types and staging. Histopathologic examination is considered as the gold standard, while the radiological examination is used for preoperative evaluation. The purpose of the present study was to evaluate susceptibility-weighted imaging SWI the in grading of infiltrative glial tumors.Materials and Methods: The SWI sequences in pre-operative magnetic resonance imaging MRI images were retrospectively assessed in a total of 67 patients mean age, 36.7 years; age range, 4–79 years; 29 female, 38 male who were diagnosed with a glial tumor based on histopathological examination. The numbers of punctate intratumoral susceptibility sign ITSS in the SWI sequence in the tumors were determined by two radiologists on a consensus-based approach. Lesions with no ITSS were graded as Grade 0, while those having 1–5, 6–15, >15 ITSS were categorized as Grade 1, Grade 2, and Grade 3, respectively. No susceptibility was classified as ITSS, “non-punctate with blurred margins” and diffuse susceptibility were categorized as >15. ITSS grades were compared to the results of histopathological grading and diagnosis.Results: The sensitivity, specificity, negative predictive value, and positive predictive value of the presence of ITSS regarding differentiating high and low-grade glial tumors were 97.6%, 88%, 95.65%, and 93.18%, respectively.Conclusion: In diffuse glial tumors, while the presence of ITSS is indicative of high-grade tumors, its absence is associated with low-grade tumors. These data suggest that the presence rather than the number of ITSS yields more information on the grade of this type of tumor

Özet

Amaç: Tümör tipleri ve evrelendirme için histopatolojik ve radyolojik inceleme gereklidir. Histopatolojik inceleme altın standart olarak kabul edilirken, preoperatif değerlendirme için radyolojik inceleme kullanılır. Bu çalışmanın amacı infiltratif glial tümörlerin evrelemesinde susceptibility ağırlıklı görüntülemenin SWI değerlendirilmesidir. Materyal ve Metot: Patolojik olarak glial tümör tanısı konmuş 67 hastanın 4–79 yaş, yaş ortalaması 36,7; 29 kadın ve 38 erkek retrospektif olarak preoperatif MRG görüntülemelerindeki SWI sekansları değerlendirilmiştir. Tüm tümörlerin SWI sekansında izlenen punktat ITSS intratumoral susceptibility sign sayıları iki radyolog tarafından konsensusla patolojik tanıları bilinmeden kör olarak hesaplanmıştır. Hiç ITSS içermeyen lezyonlar ITSS Evre 0, 1–5 ITSS içeren lezyonlar ITSS Evre 1, 6–15 ITSS içeren lezyonlar ITSS Evre 2, 15

🔖

Cite This Article

OCAK, F., YILDIZ, M. E., DİNÇER, A. (2020). Susceptibility-Weighted Imaging In Grading of Infiltrative Glial Tumors. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi, Sayı: 3, 488–493. https://ajindex.com/articles/162783

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K, Delattre J-Y. Primary brain tumours in adults. The Lancet 2012;379:1984–96. [CrossRef] Kao H-W, Chiang S-W, Chung H-W, Tsai FY, Chen C-Y. Advanced MR imaging of gliomas: an update. BioMed Res Int 2013;2013. [CrossRef] Young GS. Advanced MRI of adult brain tumors. Neurol Clin 2007;25:947–73. [CrossRef] Gasparotti R, Pinelli L, Liserre R. New MR sequences in daily practice: susceptibility weighted imaging. A pictorial essay. Insights Imaging 2011;2:335–47. [CrossRef] Black PM, Moriarty T, Alexander E, Stieg P, Woodard EJ, Gleason PL, et al. Development and implementation of intraoperative magnetic resonance imaging and its neurosurgical applications. Neurosurgery 1997;41:831–45. [CrossRef] Atlas SW. Magnetic Resonance Imaging of the Brain and Spine, 4th ed USA: Lippincott Williams & Wilkins; 2009.
  2. Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng Y-CN. Susceptibility- weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 2009;30:19–30. [CrossRef] Tong K, Ashwal S, Obenaus A, Nickerson J, Kido D, Haacke E. Susceptibility-weighted MR imaging: a review of clinical applications in children. AJNR Am J Neuroradiol 2008;29:9–17. [CrossRef] Mittal S, Wu Z, Neelavalli J, Haacke EM. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol 2009;30:232–52. [CrossRef] Kim H, Jahng G-H, Ryu C, Kim S. Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR Am J Neuroradiol 2009;30:1574–9. [CrossRef] Louis DN, Perry A, Reifenberger G, von Deimling A, Branger DF, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016;131:803–20. [CrossRef] Sehgal V, Delproposto Z, Haacke EM, Tong KA, Wycliffe N, Kido DK, et al. Clinical applications of neuroimaging with susceptibility‐ weighted imaging. J Magn Reson Imaging 2005;22:439–50. [CrossRef] Liu S, Buch S, Chen Y, Choi HS, Dai Y, Habib C, et al. Susceptibility‐ weighted imaging: current status and future directions. NMR Biomed 2017;30:e3552. [CrossRef] Sehgal V, Delproposto Z, Haddar D, Haacke EM, Sloan AE, Zamorano LJ, et al. Susceptibility‐weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging 2006;24:41–51. [CrossRef] Verclytt